RCAG
ANGO icon

Rehmann Capital Advisory Group’s AngioDynamics ANGO Stock Holding History

Rehmann Capital Advisory Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$921 Sell
50
-68
-58% -$1.33K ﹤0.01% 1570
2019
Q2 		$2.32K Buy
118
+68
+136% +$1.39K ﹤0.01% 1749
2019
Q1 		$1.14K Hold
50
– – ﹤0.01% 1899
2018
Q4 		$1.01K Hold
50
– – ﹤0.01% 1646
2018
Q3 		$1.09K Buy
+50
New +$1.11K ﹤0.01% 1964

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Rehmann Capital Advisory Group's ANGO Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its AngioDynamics (ANGO) stake by 58% in Q3 2019, selling an estimated $1.33K and leaving 50 shares worth $921. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

Rehmann Capital Advisory Group first reported a position in ANGO in Q3 2018 and has held it in 5 quarters since. The position peaked at $2.32K in Q2 2019. 173 funds tracked by Wall St. Rank hold ANGO as of Q3 2019.

  • Rehmann Capital Advisory Group held 50 shares of AngioDynamics worth $921 as of Q3 2019.
  • Rehmann Capital Advisory Group sold 68 AngioDynamics shares in Q3 2019, an estimated $1.33K.
  • AngioDynamics made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1570 holding.
  • Rehmann Capital Advisory Group first reported a position in AngioDynamics in Q3 2018 and has held it in 5 quarters since.
  • Rehmann Capital Advisory Group's AngioDynamics position peaked at $2.32K in Q2 2019.
  • 173 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.